Progesteron receptor status as a predictor of progression-free survival and overall survival in patients with early breast cancer. Background: Obese patients experience planned or unplanned reduction ...

How many of us give a “full” dose of chemotherapy to an obese patient—even in the curative setting? Dose calculation in the obese is a confusing but important puzzle for the oncologist and is becoming ...